PRODUCT NEWS

Real-time PCR reagents to detect Candida auris, Candida species, and C. auris with fluconazole resistance

Real-time PCR reagents to detect Candida auris, Candida species, and C. auris with fluconazole resistance

Candida auris detection reagents are commercially available for use in clinical and research laboratories

 

Bothell, WA, March 27, 2023 — ELITechGroup MDx LLC (EGMDx) announced availability of their Candida auris family of products, including reagents for C. auris detection, a multiplex of seven Candida pathogens, and C. auris with fluconazole resistance. This suite of real-time PCR products includes analyte specific reagents (ASR) and research use only (RUO) materials used by clinical and research laboratories.

The EGMDx product portfolio includes:

  • DSQ Alert™ Candida auris primer and probe ASRs*, for specific detection of auris
  • MGB Alert® Candida auris with fluconazole resistance RUO** Detection Reagent
  • MGB Alert® Candida species with C. auris RUO** Detection Reagent, for detection and discrimination of seven Candida species in a multiplex format

EGMDx initially released their Candida auris product family in February 2023. Product development efforts accelerated in response to a November 2022 publication from the World Health Organization, the WHO Fungal Priority Pathogens List. The WHO publication urges detection and surveillance for Candida pathogens and antifungal resistance.

In March 2023, the Centers for Disease Control published a warning in the Annals of Internal Medicine that cited a dramatic increase in the spread of C. auris between 2019 and 2021. The number of C. auris infections increased by 59%, to 756, from 2019 to 2020 and then by an additional 95%, to 1,471, in 2021. Findings state that C. auris has now been found in more than half of U.S. states. The CDC publication highlights the need for improved detection and infection control practices to prevent the spread of C. auris.

Up to 95% of all invasive Candida infections in the United States are caused by five species of Candida: C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, and C. krusei. These five species and two additional targets, C. auris and C. dubliniensis, are detectable using the new Candida species multiplex from EGMDx.

 EGMDx is an innovative company that realizes the need for flexibility and versatility to optimize lab infrastructure and capacity. The release of their Candida family of products has been anticipated by many hospital laboratories, including lab partners involved in developing the products. “Our Candida auris family of reagents is compatible with many open channel systems and can help optimize molecular lab equipment,” said Scott Johnston, General Manager. Johnston added, “We’re proud to have an agile team that can quickly respond to clinical and public health needs.”

EGMDx reagents are compatible with the company’s proprietary ELITe BeGenius® automated sample to result platform, in addition to third party open channel instrument systems. The company is a dedicated molecular diagnostics manufacturer offering reagents and instrument systems to detect infectious diseases.

Please visit www.elitechgroup.com/molecular-diagnostics-us to learn more.

*Analyte Specific Reagent. Analytical and performance characteristics are not established.

**For Research Use Only. Not for use in diagnostic procedures.

About ELITechGroup MDx LLC

ELITechGroup MDx serves the needs of clinical and research laboratories alike, offering an extensive range of molecular diagnostics products, including the fully automated sample-to-result ELITe BeGenius® and ELITe InGenius® instruments and a growing menu of infectious disease tests and reagents featuring innovative chemistries to optimize sensitivity and specificity. MGB Alert products utilize the original minor groove binder probe technology and offer the flexibility of PCR-based detection or melt curve analysis. DSQ Alert products feature the duplex stabilizing quencher, the latest evolution of hydrolysis probe-based real-time PCR. Other proprietary chemistries designed for optimum product performance include the original azo dye Eclipse® Dark Quencher, AquaPhluor® fluorescent dyes, and nucleotide Superbases™.

 

Contact

Scott Johnston, General Manager

Phone 925-495-9492

Email s.johnston@elitechgroup.com

 

M501247 R0

Latest news

NEWSROOM

Redesigned enterovirus and parechovirus real-time PCR reagents

Newly released and commercially available for use in clinical and research laboratories Bothell, WA, November 7, 2023 — ELITechGroup MDx LLC (EGMDx) announced availability of their redesigned enterovirus and parechovirus analyte specific reagents* (ASR). The ASRs are designed to be used in the development of real-time PCR assays and were…

Honoring ELITechGroup’s Legacy: The MGB Stabilizer Revolution

In the world of molecular diagnostics, we often encounter groundbreaking innovations that deserve a tribute. Today, we pay homage to a pivotal moment in history—the invention of the MGB stabilizer, i.e., Minor Groove Binder stabilizer, by ELITechGroup MDx LLC (formerly known as Epoch Biosciences) in 1995. This unsung hero has…

ELITechGroup obtains new IVDR certificate for PCR assays

After the release of the first IVDR certificate at the beginning of the year ELITech Group continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories. The company is fully committed to delivering its entire portfolio of nearly 60 molecular assays as IVDR compliant by 2026…

Let us help you

For general inquiries, please use the links to the right. The Contact link leads to a brief online form, and the Support link offers general phone and email information. Someone will be in touch with you soon.